We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

3l17

From Proteopedia

Revision as of 10:41, 16 December 2009 by OCA (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search

Unreleased structure

The entry 3l17 is ON HOLD

Authors: Wiesmann, C., Sutherlin, D.P., Sampath, D., Berry, M., Castanedo, G., Heffron, T., Zhu, B-Y., Lewis, C., Olivero, A.

Description: Discovery of (thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer

Page seeded by OCA on Wed Dec 16 12:41:09 2009

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/3l17"
Personal tools